Frequency-specific stimulation of subthalamic nucleus subregions to improve inhibitory control in Parkinson's disease
Official title: Frequency-dependent Modulation of Inhibitory Control Via Subthalamic Nucleus Subregional Stimulation in Parkinson's Disease
Run by Beijing Tiantan Hospital · NCT07022522 · Data updated 2026-11-12
This tests whether stimulating different parts of the subthalamic nucleus at low (5 Hz) or high (130 Hz) frequencies can improve inhibitory control in people with Parkinson's disease who have deep brain stimulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | February 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | June 15, 2025 |
| Trial ID | NCT07022522 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 40–80 with idiopathic Parkinson's disease who meet DBS indications and do not have dementia or sensory impairments that would interfere with cognitive testing.
✕Probably not a fit
Patients with significant psychiatric disorders, dementia, major post-DBS complications (e.g., hemorrhage, electrode misplacement), sensory impairments, or other conditions that impair cognition are unlikely to benefit from the tested interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with idiopathic Parkinson's disease who meet indications for DBS will receive sequential stimulation conditions targeting either the motor or associative subregions of the subthalamic nucleus at 5 Hz or 130 Hz, plus a no-stimulation control. During each condition they will perform cognitive tasks that measure inhibitory control to compare performance across frequencies and contact locations. The design compares within-subject effects of frequency and subregion to identify patterns that improve or worsen inhibitory control. Results will inform whether specific frequency–subregion combinations produce reliably better cognitive outcomes in the acute setting.
Why it matters
Potential benefit: If successful, this could allow clinicians to tailor DBS frequency and contact location to reduce impulsivity and improve attention and daily functioning for patients with Parkinson's disease.
How similar studies have gone: Prior work shows STN stimulation frequency and contact location can influence motor and cognitive outcomes, but applying frequency-specific stimulation across defined STN subregions specifically to improve inhibitory control is a relatively novel approach with mixed prior results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 40-80 years old; 2. Diagnosed with idiopathic Parkinson's disease; 3. Meeting the indications for DBS surgery. Exclusion Criteria: 1. Patient declined to participate in the study; 2. Presence of significant post-DBS complications (e.g., intracranial hemorrhage, cerebral edema, electrode misplacement); 3. Significant psychiatric disorders or dementia (MMSE score \<20 for uneducated; \<23 for 1-6 years education; \<27 for ≥7 years education); 4. Visual or auditory impairment affecting cognitive task performance 5. History of conditions potentially impairing cognitive function.
Where it's running
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Jianguo Zhang, M.D., Ph.D. — Beijing Tiantan Hospital
- Study coordinator: Hutao Xie
- Email: xieht0123@163.com
- Phone: +8618756921517
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Patterned deep brain stimulation delivered at home for Parkinson's
This study will test whether three types of patterned deep brain stimulation can be used safely and comfortably at home in people with Parkinson's who already have stable bilateral STN or GPi Boston Scientific DBS systems.
-
Mediterranean diet for managing weight and body composition after bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease
It will see if following a Mediterranean diet for three months after bilateral subthalamic nucleus deep brain stimulation helps adults with Parkinson's control weight and improve body composition.
-
How deep brain stimulation affects thinking and memory in Parkinson's
This project will use MRI scans to see if subthalamic nucleus deep brain stimulation (DBS) changes brain networks and relates to thinking or memory declines in people with Parkinson's disease who already have DBS implants.
-
Advanced brain imaging for improving deep brain stimulation in Parkinson's and essential tremor patients
This study is testing if advanced brain imaging can help doctors place and program deep brain stimulation better for people with Parkinson's disease and essential tremor to improve their movement.
-
Adaptive versus continuous subthalamic nucleus deep brain stimulation for people with Parkinson's
This project will try adaptive DBS versus regular continuous DBS in people with Parkinson's who already have Medtronic Percept STN implants to see if one gives more daily ON time without troublesome dyskinesia over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.